Publicaciones en colaboración con investigadores/as de University of Leipzig (16)

2023

  1. Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))

    Nature communications

  2. Genetic Associations between Modifiable Risk Factors and Alzheimer Disease

    JAMA Network Open, Vol. 6, Núm. 5

  3. Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 36

2022

  1. Association of Rare APOE Missense Variants V236E and R251G with Risk of Alzheimer Disease

    JAMA Neurology, Vol. 79, Núm. 7, pp. 652-663

  2. New insights into the genetic etiology of Alzheimer's disease and related dementias

    Nature genetics, Vol. 54, Núm. 4, pp. 412-436

2021

  1. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Nature communications, Vol. 12, Núm. 1, pp. 3417

2017

  1. TSHB mRNA is linked to cholesterol metabolism in adipose tissue

    FASEB Journal, Vol. 31, Núm. 10, pp. 4482-4491

2009

  1. Comparison of population health status in six european countries results of a representative survey using the EQ-5D questionnaire

    Medical Care, Vol. 47, Núm. 2, pp. 255-261

2008

  1. The relation between body mass index, mental health, and functional disability: A European population perspective

    Canadian Journal of Psychiatry, Vol. 53, Núm. 10, pp. 679-688

2007

  1. Treatment adequacy for anxiety and depressive disorders in six European countries

    British Journal of Psychiatry, Vol. 190, Núm. FEB., pp. 172-173

2004

  1. 12-Month comorbidity patterns and associated factors in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

    Acta Psychiatrica Scandinavica, Supplement, Vol. 109, Núm. 420, pp. 28-37

  2. Disability and quality of life impact of mental disorders in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

    Acta Psychiatrica Scandinavica, Supplement, Vol. 109, Núm. 420, pp. 38-46

  3. Prevalence of mental disorders in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

    Acta Psychiatrica Scandinavica, Supplement, Vol. 109, Núm. 420, pp. 21-27

  4. Psychotropic drug utilization in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

    Acta Psychiatrica Scandinavica, Supplement, Vol. 109, Núm. 420, pp. 55-64

  5. Sampling and methods of the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

    Acta Psychiatrica Scandinavica, Supplement, Vol. 109, Núm. 420, pp. 8-20

  6. Use of mental health services in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

    Acta Psychiatrica Scandinavica, Supplement, Vol. 109, Núm. 420, pp. 47-54